Thursday 11th May 2017
Drugs target cell pathways altered in scleroderma
Evidence suggests drugs in scleroderma trials have beneficial effects on skin, lung function and the heart.
Thursday 11th May 2017
Evidence suggests drugs in scleroderma trials have beneficial effects on skin, lung function and the heart.
Sunday 4th September 2016
This information is intended for residents of the UK Now Enroling Patients with Diffuse Cutaneous Systemic Sclerosis (dcSSc) also called Scleroderma Have you or someone you know been diagnosed with diffuse cutaneous systemic sclerosis? Would you/they be interested in participating in a clinical research study?
Wednesday 30th March 2016
Cytori Therapeutics has enrolled and treated its 40th patient with scleroderma in the Phase 3 STAR clinical trial for ECCS-50, marking 50 percent of target enrollment.